Physicians and Insider Trading

Recent high-profile cases demonstrate that physicians and scientists with access to confidential information about clinical trials or corporate governance have engaged in insider trading, which undermines the legitimate benefits of their involvement in business decision-making. Minimizing insider trading requires robust education, strictly enforced contracts, and selective prohibitions on high-risk activities such as expert consulting networks for individuals with access to valuable inside information.